相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Shirish Gadgeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Salvage surgery after chemotherapy and/or radiotherapy including SBRT and proton therapy: A consecutive analysis of 38 patients
Aki K. Kobayashi et al.
LUNG CANCER (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: A case report
Toshiyuki Sumi et al.
THORACIC CANCER (2020)
Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer Patients
G. Daniel Grass et al.
CLINICAL LUNG CANCER (2019)
Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer
Laura Romero-Vielva et al.
LUNG CANCER (2019)
Efficacy of chemoradiotherapy versus radiation alone in patients with inoperable locally advanced non-small-cell lung cancer A meta-analysis and systematic review
Ming-Szu Hung et al.
MEDICINE (2019)
Salvage Surgery After Chemotherapy or Chemoradiotherapy for Initially Unresectable Lung Carcinoma
Makoto Sonobe et al.
ANNALS OF THORACIC SURGERY (2019)
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease
Antonin Levy et al.
EUROPEAN JOURNAL OF CANCER (2019)
Successful salvage surgery following multimodal therapy in a patient who harboured ALK-rearranged advanced lung adenocarcinoma with multiple organ metastases
Yoshitsugu Horio et al.
RESPIROLOGY CASE REPORTS (2019)
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors
Matthew J. Bott et al.
ANNALS OF THORACIC SURGERY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A review of guidelines for lung cancer
Paolo Bironzo et al.
JOURNAL OF THORACIC DISEASE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Surgery of primary non-small cell lung cancer with oligometastasis: analysis of 172 cases
Zhe Wang et al.
JOURNAL OF THORACIC DISEASE (2018)
Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review
Chris Dickhoff et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Salvage surgery for local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review
Chris Dickhoff et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. E. Postmus et al.
ANNALS OF ONCOLOGY (2017)
Salvage surgery for local recurrence after carbon ion radiotherapy for patients with lung cancer
Teruaki Mizobuchi et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
Current Topics on Salvage Thoracic Surgery in Patients with Primary Lung Cancer
Hidetaka Uramoto
ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Daniel R. Gomez et al.
LANCET ONCOLOGY (2016)
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer
C. Dickhoff et al.
LUNG CANCER (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases
Tomoyuki Hishida et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2016)
Approach for oligometastasis in non-small cell lung cancer
Hidemi Suzuki et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2016)
New Strategies in Stereotactic Radiotherapy for Oligometastases
David A. Palma et al.
CLINICAL CANCER RESEARCH (2015)
The oligometastatic state-separating truth from wishful thinking
David A. Palma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gerard A. Silvestri et al.
CHEST (2013)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer: The Hoosier Oncology Group and US Oncology
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: A meta-analysis
Maria Q. Baggstrom et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
分享论文
